BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 17442739)

  • 1. Focal segmental glomerulosclerosis is not a sufficient predictor of renal outcome in patients with membranous nephropathy.
    Heeringa SF; Branten AJ; Deegens JK; Steenbergen E; Wetzels JF
    Nephrol Dial Transplant; 2007 Aug; 22(8):2201-7. PubMed ID: 17442739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new index for the outcome of focal segmental glomerulosclerosis.
    Chan L; Danyi Y; Cheng C
    Sci Rep; 2024 Apr; 14(1):8278. PubMed ID: 38594302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of focal segmental glomerulosclerosis after anabolic steroid abuse.
    Herlitz LC; Markowitz GS; Farris AB; Schwimmer JA; Stokes MB; Kunis C; Colvin RB; D'Agati VD
    J Am Soc Nephrol; 2010 Jan; 21(1):163-72. PubMed ID: 19917783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urine albumin-to-creatinine ratio diurnal variation rate predicts outcomes in idiopathic membranous nephropathy.
    Chen X; Zhang Y; Yan L; Xie Y; Li S; Zhuang Y; Wang L
    Clin Exp Nephrol; 2024 May; 28(5):409-420. PubMed ID: 38240880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathologic characteristics, pathology, and prognosis of 77 dogs with focal segmental glomerulosclerosis.
    Lorbach SK; Hokamp JA; Quimby JM; Cianciolo RE
    J Vet Intern Med; 2020 Sep; 34(5):1948-1956. PubMed ID: 33463760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study of urinary markers of different podocytopathies by proteomic analysis].
    Vinogradov AA; Chebotareva NV; Bugrova AE; Brzhozovskiy AG; Krasnova TN; Nasibullina KZ; Kononikhin AS; Moiseev SV
    Ter Arkh; 2023 Aug; 95(6):457-461. PubMed ID: 38158963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis.
    Rheault MN; Alpers CE; Barratt J; Bieler S; Canetta P; Chae DW; Coppock G; Diva U; Gesualdo L; Heerspink HJL; Inrig JK; Kirsztajn GM; Kohan D; Komers R; Kooienga LA; Lieberman K; Mercer A; Noronha IL; Perkovic V; Radhakrishnan J; Rote W; Rovin B; Tesar V; Trimarchi H; Tumlin J; Wong MG; Trachtman H;
    N Engl J Med; 2023 Dec; 389(26):2436-2445. PubMed ID: 37921461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TRPC6 single nucleotide polymorphisms and progression of idiopathic membranous nephropathy.
    Hofstra JM; Coenen MJ; Schijvenaars MM; Berden JH; van der Vlag J; Hoefsloot LH; Knoers NV; Wetzels JF; Nijenhuis T
    PLoS One; 2014; 9(7):e102065. PubMed ID: 25019165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Prospective Study on Complement Activation Distinguishes Focal Segmental Glomerulosclerosis from Minimal Change Disease.
    Cambier A; Patey N; Royal V; Gougeon F; Genest DS; Brachemi S; Bollée G; Merlen C; Bonnefoy A; Lapeyraque AL; Troyanov S
    Kidney Int Rep; 2024 Mar; 9(3):661-670. PubMed ID: 38481495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CMV-associated collapsing focal segmental glomerulosclerosis after kidney transplant in a pediatric patient.
    Parr MFE; Hidalgo G; Goldstein MJ; Batal I; Lieberman KV; Amoruso MR; Baer AZ; Jain NG
    Pediatr Transplant; 2023 Aug; 27(5):e14535. PubMed ID: 37128132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scoring system for renal pathology in Fabry disease: report of the International Study Group of Fabry Nephropathy (ISGFN).
    Fogo AB; Bostad L; Svarstad E; Cook WJ; Moll S; Barbey F; Geldenhuys L; West M; Ferluga D; Vujkovac B; Howie AJ; Burns A; Reeve R; Waldek S; Noël LH; Grünfeld JP; Valbuena C; Oliveira JP; Müller J; Breunig F; Zhang X; Warnock DG;
    Nephrol Dial Transplant; 2010 Jul; 25(7):2168-77. PubMed ID: 19833663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase 1, single-dose study of fresolimumab, an anti-TGF-β antibody, in treatment-resistant primary focal segmental glomerulosclerosis.
    Trachtman H; Fervenza FC; Gipson DS; Heering P; Jayne DR; Peters H; Rota S; Remuzzi G; Rump LC; Sellin LK; Heaton JP; Streisand JB; Hard ML; Ledbetter SR; Vincenti F
    Kidney Int; 2011 Jun; 79(11):1236-43. PubMed ID: 21368745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative urinary proteomic and metabolomic analysis between renal aa amyloidosis and membranous nephropathy with clinicopathologic correlations.
    Ozbek DA; Koc SC; Özkan NE; Kablan SE; Yet I; Uner M; Ozlu N; Nemutlu E; Lay I; Ayhan AS; Yildirim T; Arici M; Yilmaz SR; Erdem Y; Altun B
    J Proteomics; 2024 Feb; 293():105064. PubMed ID: 38154551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV associated renal disease: a pilot study from north India.
    Gupta V; Gupta S; Sinha S; Sharma SK; Dinda AK; Agarwal SK; Tiwari SC; Ekka M
    Indian J Med Res; 2013 May; 137(5):950-6. PubMed ID: 23760382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary matrix metalloproteinase-7 is a sensitive biomarker to evaluate renal tubular injury in patients with minimal change disease and focal segmental glomerulosclerosis.
    Yin DY; Hou GL; Yang XQ; Bi LL; Mei XF; Bai MK; Zhou L; Zhu S; Huang YJ
    Clin Kidney J; 2024 Jan; 17(1):sfad027. PubMed ID: 38186883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fractional excretion of total protein predicts renal prognosis in Japanese patients with primary membranous nephropathy.
    Kuno H; Kanzaki G; Sasaki T; Okabayashi Y; Haruhara K; Yokote S; Koike K; Ueda H; Tsuboi N; Yokoo T
    Clin Kidney J; 2024 May; 17(5):sfae071. PubMed ID: 38699483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring kidney biopsy findings in congenital heart diseases: Insights beyond cyanotic nephropathy.
    Juarez-Villa JD; Zepeda-Quiroz I; Toledo-Ramírez S; Gomez-Johnson VH; Pérez-Allende F; Garibay-Vega BR; Rodríguez Castellanos FE; Moguel-González B; Garcia-Cruz E; Lopez-Gil S
    World J Nephrol; 2024 Mar; 13(1):88972. PubMed ID: 38596269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spectrum of non-diabetic kidney diseases in patients with type 2 DM who underwent kidney biopsy in Egypt.
    Kaawele S; Elkeraie AF; Youssef E; Elrggal M; Elrggal M; Zyada R; Esmail W
    Kidney Blood Press Res; 2024 May; ():. PubMed ID: 38754398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aggressive treatment may be needed for idiopathic membranous nephropathy with focal segmental glomerulosclerosis lesions.
    Cheng P; Xie Q; Liu S; Liu X; Wang L; Hao CM
    Rev Assoc Med Bras (1992); 2024; 70(4):e20230871. PubMed ID: 38716932
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.